炎症性肠病:2017年全球疾病负担研究的估计
该研究基于2017年全球疾病负担(GBD)数据库,分析1990至2017年炎症性肠病(IBD)的年龄标化患病率、伤残调整生命年(DALYs)及其组分(YLDs和YLLs),按地区、社会人口指数(SDI)、性别和年龄分层。结果显示高SDI国家患病率与负担较高,但全球DALYs下降12%,主要归因于早死所致寿命损失(YLLs)减少26%;低SDI国家DALYs中86%为YLLs,而高SDI国家71%为残疾所致(YLDs)。儿童负担下降显著(DALYs -39%,YLLs -52%),但近10年中高SDI国家患病率趋于平稳,低SDI国家急剧上升。
要点
- 全球IBD患病率1990-2017年增加6%,但DALYs下降12%。
- 低SDI国家DALYs中86%为早死所致,高SDI国家71%为残疾所致。
- 儿童IBD负担显著改善(DALYs -39%,YLLs -52%)。
核心结论
- 近三十年IBD诊疗显著改善,全球负担和早死所致寿命损失逐步下降,但发展中国家发病率上升且早死负担高,需关注。
研究设计与样本
- 基于GBD 2017数据库的回顾性分析,报告1990-2017年年龄标化患病率、DALYs、YLDs和YLLs,按地区、SDI、性别和年龄分层。
主要发现
- IBD患病率和负担地区差异大,高SDI国家尤其高。
- 1990至2017年患病率增加6%,DALYs下降12%,YLLs下降26%。
- 2017年低SDI国家DALYs中86%为YLLs,高SDI国家71%为YLDs。
- 儿童DALYs下降39%,YLLs下降52%。
- 近10年中高SDI国家患病率趋于平稳,低SDI国家急剧上升。
临床怎么用
- 关注低SDI国家IBD早死负担,加强早期诊断和治疗可及性。
- 高SDI国家应重视残疾管理,改善患者生活质量。
- 儿童IBD诊疗改善显著,可借鉴相关经验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Inflammatory bowel disease (IBD) is a significant health problem in the industrialised world, currently increasing in developing countries. Understanding the global burden of IBD is important to tackle increasing disease occurrence. AIM: To investigate the GBD (Global Burden of Disease) 2017 Study Database summarising and critically evaluating the global burden of IBD METHODS: We presented age-standardised prevalence estimates, disability-adjusted life years (DALYs) and its components: years lived with disability (YLDs) and years of life lost (YLLs) due to premature mortality. We reported these measures from 1990 to 2017 and stratified by region, socio-demographic index (SDI), gender and age group. RESULTS: The latest IBD prevalence and burden estimates varied widely across regions, and were particularly elevated in high-SDI countries. Despite an increasing prevalence from 1990 to 2017 (+6%), the IBD burden decreased (DALYs -12%). This decrease was driven by IBD-associated premature mortality (YLLs -26%). This measure represented a high share of disease burden in low-SDI countries (86% of DALYs), whereas disability constituted the predominant component in high-SDI countries (71%) in 2017. Disease burden decreased particularly in children (DALYs -39% and YLLs -52%). In the last 10 years, however, prevalence plateaued in middle- to high-SDI countries and steeply increased in low-SDI countries. CONCLUSIONS: These findings highlight significant improvements in IBD care in the last three decades, particularly in children. The global burden of IBD and premature mortality have progressively decreased. The increase in disease frequency observed in developing countries is worrying, especially considering the high associated premature mortality in these areas.
引用
- Piovani D, Danese S, Peyrin-Biroulet L, et al. Inflammatory bowel disease: estimates from the global burden of disease 2017 study. Aliment Pharmacol Ther. 2019. PMID: 31660629. doi:10.1111/apt.15542
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。